Edesa Biotech Reports Dermatitis Study Enrolling Faster than Expected

Go back to Edesa Biotech Reports Dermatitis Study Enrolling Faster than Expected
(NASDAQ: EDSA) Delayed: 4.51 -0.15 (3.22%)
Previous Close $4.66    52 Week High
Open $4.70    52 Week Low
Day High $4.84    P/E N/A 
Day Low $4.47    EPS
Volume 17,869